- Home
- Publications
- Publication Search
- Publication Details
Title
FDG PET/CT imaging as a biomarker in lymphoma
Authors
Keywords
Lymphoma, FDG PET, Metabolic tumour volume, Deauville criteria, SUV, Response to treatment
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 42, Issue 4, Pages 623-633
Publisher
Springer Nature
Online
2015-01-08
DOI
10.1007/s00259-014-2973-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
- (2014) R. Vaidya et al. ANNALS OF ONCOLOGY
- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) D. A. Eichenauer et al. ANNALS OF ONCOLOGY
- Guidelines for the first line management of classical Hodgkin lymphoma
- (2014) George A. Follows et al. BRITISH JOURNAL OF HAEMATOLOGY
- F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
- (2014) Rosj Gallicchio et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
- (2014) Dirk Hasenclever et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells
- (2014) Michel Meignan EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
- (2014) Michel Meignan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
- (2014) Salim Kanoun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
- (2014) Myriam Sasanelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
- (2014) A. Gallamini et al. HAEMATOLOGICA
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- In Vivo Treatment Sensitivity Testing With Positron Emission Tomography/Computed Tomography After One Cycle of Chemotherapy for Hodgkin Lymphoma
- (2014) Martin Hutchings et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Hodgkin Lymphoma: A 50-Year Perspective
- (2014) George P. Canellos et al. JOURNAL OF CLINICAL ONCOLOGY
- Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
- (2014) John M.M. Raemaekers et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma
- (2014) Carsten Kobe et al. JOURNAL OF CLINICAL ONCOLOGY
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study
- (2014) Maurizio Martelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim 18F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients
- (2014) C. Rossi et al. JOURNAL OF NUCLEAR MEDICINE
- Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients
- (2014) Carlo Gambacorti Passerini et al. JNCI-Journal of the National Cancer Institute
- 18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer
- (2014) Stéphanie Lheureux et al. Translational Oncology
- Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
- (2014) C D Hudson et al. Cell Death & Disease
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
- (2014) Judith Trotman et al. Lancet Haematology
- Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
- (2013) Christine A. Ciunci et al. CANCER
- An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
- (2013) Emmanuel Itti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- XIV. The rationale for combining targeted and biological anti-lymphoma drugs
- (2013) Anas Younes HEMATOLOGICAL ONCOLOGY
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
- (2013) A. Biggi et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma
- (2013) Nathalie Nols et al. LEUKEMIA & LYMPHOMA
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
- (2012) Sylvia Hartmann et al. BMC CANCER
- Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma
- (2012) Tae Min Kim et al. CANCER
- Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy
- (2012) Paolo G Gobbi et al. HEMATOLOGICAL ONCOLOGY
- Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
- (2012) Jehan Dupuis et al. JOURNAL OF CLINICAL ONCOLOGY
- International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era
- (2012) Alden A. Moccia et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26–27 September 2011 and Menton 2011 consensus
- (2012) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
- (2011) Moo-Kon Song et al. ANNALS OF HEMATOLOGY
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
- (2011) Judith Trotman et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimising the lymphoma response criteria in the era of targeted therapy
- (2011) Anas Younes et al. LANCET ONCOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma
- (2011) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- Crizotinib in Anaplastic Large-Cell Lymphoma
- (2011) Carlo Gambacorti-Passerini et al. NEW ENGLAND JOURNAL OF MEDICINE
- The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
- (2011) E Derenzini et al. Blood Cancer Journal
- Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group
- (2010) Caroline Bodet-Milin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma
- (2010) A. Gallamini HAEMATOLOGICA
- [18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy
- (2009) Wen Wee Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
- (2009) Massimo Federico et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- (2009) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome
- (2009) Maroun Karam et al. NUCLEAR MEDICINE COMMUNICATIONS
- Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma
- (2008) C. Bodet-Milin et al. HAEMATOLOGICA
- Early Prediction of Response to Sunitinib After Imatinib Failure by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Gastrointestinal Stromal Tumor
- (2008) John O. Prior et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started